KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $101.8 million.

  • Opko Health's Cost of Revenue fell 23.77% to $101.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $415.5 million, marking a year-over-year decrease of 31.61%. This contributed to the annual value of $494.6 million for FY2024, which is 9.30% down from last year.
  • Latest data reveals that Opko Health reported Cost of Revenue of $101.8 million as of Q3 2025, which was down 5.24% from $107.4 million recorded in Q2 2025.
  • Over the past 5 years, Opko Health's Cost of Revenue peaked at $339.4 million during Q1 2021, and registered a low of $99.0 million during Q4 2024.
  • For the 3-year period, Opko Health's Cost of Revenue averaged around $123.3 million, with its median value being $113.0 million (2023).
  • In the last 5 years, Opko Health's Cost of Revenue soared by 176.21% in 2021 and then tumbled by 53.29% in 2024.
  • Over the past 5 years, Opko Health's Cost of Revenue (Quarterly) stood at $271.7 million in 2021, then dropped by 28.33% to $194.8 million in 2022, then increased by 8.81% to $211.9 million in 2023, then plummeted by 53.29% to $99.0 million in 2024, then fell by 23.77% to $101.8 million in 2025.
  • Its Cost of Revenue stands at $101.8 million for Q3 2025, versus $107.4 million for Q2 2025 and $107.3 million for Q1 2025.